Determinants of survival in patients with brain metastases from cutaneous melanoma

2010160 citationsJournal Articlehybrid Open Access

Authors

Michael D. Staudt · University of Tübingen

Konstantinos Lasithiotakis · Berufsverband der Deutschen Dermatologen

Ulrike Leiter · Berufsverband der Deutschen Dermatologen

Friedegund Meier · Berufsverband der Deutschen Dermatologen

Thomas Eigentler · Berufsverband der Deutschen Dermatologen

M. Bamberg · University of Tübingen

Marcos Tatagiba

Abstract

Applied treatment and serum lactate dehydrogenase levels were independent predictors of survival of patients with brain metastases from cutaneous melanoma. Patients receiving local therapy have overall survival comparable with general stage IV melanoma patients.

Topics & Keywords

Brain Metastases and Treatment Cutaneous Melanoma Detection and Management Melanoma and MAPK Pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Cancer

Volume 102, Issue 8, pp. 1213-1218

DOI: 10.1038/sj.bjc.6605622

Field-Weighted Citation Impact: 12.51